( OTC-BB:ARNI,OTC-PINK:ARNI,OTC-QB:ARNI )

News from arno therapeutics, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 15, 2013, 18:00 ET Arno Therapeutics to Present Positive, New Data Supporting the Potential of Onapristone in Endometrial and Breast Cancers at ASCO 2013 Annual Meeting

 Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...


Jan 31, 2013, 12:00 ET Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors

 Arno Therapeutics, Inc. (OTCBB: ARNI), a clinical-stage biopharmaceutical company focused on the development of oncology therapeutics, today...


May 11, 2009, 10:27 ET FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced that the U.S. Food and Drug...


May 04, 2009, 09:05 ET Arno Therapeutics to Deregister its Common Stock under the Exchange Act

Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced...


Mar 31, 2009, 09:59 ET Arno Therapeutics Reports 2008 Year-End Financial Results

Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced...


Mar 17, 2009, 08:30 ET FDA Accepts IND for Arno Therapeutics' Pan-DAC / Akt Inhibitor, AR-42

Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced...


Nov 14, 2008, 09:00 ET Arno Therapeutics Announces Third Quarter 2008 Financial Results

Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced...


Nov 03, 2008, 09:00 ET Arno Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced...


Aug 18, 2008, 01:00 ET Arno Therapeutics Announces Second Quarter 2008 Financial Results

FAIRFIELD, N.J., Aug. 18 /PRNewswire-FirstCall/-- Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company...


Jun 04, 2008, 01:00 ET Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.

FAIRFIELD, N.J., June 4 /PRNewswire-FirstCall/ -- Arno Therapeutics, Inc., a biopharmaceutical company focused on developing therapies for the...


Jan 28, 2008, 00:00 ET Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds

FAIRFIELD, N.J., Jan. 28 /PRNewswire/ -- Arno Therapeutics, Inc., a privately held drug development company, announced that it has entered into...